Line the GLP-1 medications up by schedule and the pattern looks like it was assigned by lottery. Ozempic and Wegovy, once a week. Mounjaro and Zepbound, once a week. Trulicity, once a week. Saxenda and Victoza, every single day. Rybelsus, every single morning. Byetta, twice a day.
One family, one receptor, wildly different rhythms. There is no marketing reason behind it and no clinical preference. Add one more column to that list and the whole thing stops looking arbitrary and starts looking close to inevitable.
Dosing interval follows half-life
The column is half-life: the time your body needs to clear half of whatever is circulating.
The principle that follows is almost mechanical. A medication has to be redosed before its level falls too far, so the gap between doses is set by how fast the level falls. A molecule cleared in a couple of hours needs redosing in hours. A molecule cleared over days can be left alone for a week.
Too far is the part that carries the judgment. A dosing schedule is trying to keep the level inside a useful band: high enough to do the job through the whole interval, without needing a dose so large that the peak becomes a problem. Redose too rarely and the level swings; redose too often and you have handed someone a routine they will struggle to keep. The interval that balances those pressures tends to land in the same neighborhood as the half-life.
That is the whole idea, and it is worth holding onto, because it turns a confusing product list into a single sorted column.
The class, sorted by cadence
Here is the family with the number that decides its schedule. The half-lives are approximate published figures.
| Medication | Molecule | Half-life | Cadence |
|---|---|---|---|
| Ozempic, Wegovy | Semaglutide | About 1 week | Once weekly |
| Mounjaro, Zepbound | Tirzepatide | About 5 days | Once weekly |
| Trulicity | Dulaglutide | About 5 days | Once weekly |
| Rybelsus | Oral semaglutide | About 1 week | Once daily |
| Saxenda, Victoza | Liraglutide | About 13 hours | Once daily |
| Adlyxin | Lixisenatide | About 3 hours | Once daily |
| Byetta | Exenatide | About 2.4 hours | Twice daily |
Read down the half-life column and the cadence column mostly writes itself. Hours means several times a day or once a day; days means once a week.
Two rows do not fall neatly out of that rule, and it is more honest to name them than to pretend the principle is a law. Lixisenatide is the quiet one: a half-life measured in hours paired with once-daily dosing, which is a reminder that the interval on a label is decided by a fuller clinical picture than plasma half-life alone. Rybelsus is the loud one, and it gets its own section below.
The consequences of these numbers run deeper than the calendar, incidentally. A long half-life is also what produces the month-long climb to a stable level that surprises so many people in their first weeks, which we cover in steady state in plain English.
How weekly became possible at all
The starting point is a number that makes the entire drug class make sense. The GLP-1 your own gut releases has a half-life of less than two minutes, because an enzyme called DPP-4 takes it apart almost as fast as it appears. Our explainer on the GLP-1 hormone tells that part of the story.
So a weekly injection is not a mild improvement on the natural hormone. It is a difference of scale rather than of degree, and getting there took two changes to the molecule.
The proof that any of it was possible did not come from a drawing board. It came from exenatide, a molecule found in gila monster venom that engages the human GLP-1 receptor while resisting rapid breakdown, and so lasts hours rather than minutes. Hours is not a week, and Byetta sits at the bottom of the table above for exactly that reason. But it established the principle, and everything longer-acting is a variation on making that resistance last.
- Make it resist the enzyme. The molecule is modified so DPP-4 cannot take it apart the way it dismantles the natural hormone. That alone buys hours instead of minutes.
- Give it something big to hold onto. A fatty acid chain is attached to the molecule, and that chain binds to albumin, an abundant protein circulating in the blood. Bound to albumin, the medication is shielded from the enzyme and is also cleared far more slowly by the kidneys, which filter small things out much more readily than large ones.
That second trick is where the daily and weekly schedules part ways, and the difference is surprisingly physical. Semaglutide carries a fatty diacid chain that binds albumin strongly, and its half-life is about a week. Liraglutide carries a shorter fatty acid chain, and its half-life is about 13 hours. Same strategy, different grip, and the result is one medication you take on Tuesdays and another you take every night.
Which is worth sitting with for a second. The weekly cadence was not a convenience feature added at the end of development. It is the thing the molecule was engineered to achieve, and the schedule printed on the box is the visible result of that engineering.
Rybelsus is daily for an entirely different reason
Rybelsus is the row that breaks the pattern, and the reason it breaks it is genuinely interesting.
Rybelsus is oral semaglutide. Not a cousin of the injectable, not a lighter version: the same long-lasting molecule that supports a weekly injection under a different brand name. Its half-life has not changed. It is still about a week.
It is daily because of absorption. Only a small fraction of a swallowed dose makes it into the bloodstream, and that fraction depends on conditions that are easy to disturb: an empty stomach, plain water only and not much of it (up to about 4 oz, or 120 ml), and a wait of at least 30 minutes before any food, other drink or other oral medication. Taking it every morning under those conditions is what makes the arriving amount dependable. Our guide to tracking Rybelsus covers the morning routine in full.
The general lesson is a useful one to carry. How often you take something is answered by the whole delivery system, not by the molecule on its own. A long-lasting drug that only partly gets in still needs topping up.
What cadence means for your log
Here is the practical payoff, and it is the part most people discover the hard way: weekly and daily medications fail in completely different ways.
A missed weekly dose is a visible gap. There are 52 of these events in a year, each one distinctive, and one of them not happening leaves an obvious hole. The hard question with a weekly medication is almost never did I take it, it is exactly when did I take it, because the official late-dose rules are counted in days and the spacing rules in hours. A guess of sometime last Tuesday cannot be measured against a five-day window; a timestamp can. Our missed dose guide collects those windows for every medication in the family.
A missed daily dose is a needle in a haystack. There are 365 near-identical events in a year, and yesterday's blurs into the day before's within about a week. The characteristic daily failure is not forgetting so much as uncertainty: standing in the bathroom at ten at night genuinely unable to say whether tonight already happened. The log's job here is not measurement but recall, answered in two seconds, and the habit that makes it work is anchoring the dose to something you already do at the same time every day.
Cadence changes the rest of the routine too. A weekly injector gives each patch of skin a week to recover; a daily injector puts seven injections a week into the same three approved regions, which makes a rotation system worth having rather than optional, as our guide to injection site rotation explains. And a twice-daily medication like Byetta simply doubles the number of moments that have to survive a busy day.
The takeaway
The schedule on your box is not a preference and not a marketing decision. It is a readout of how long the molecule survives in your blood, and in Rybelsus's case, of how much of it gets in at all.
Knowing which one you are holding tells you what kind of consistency it is asking for. A weekly injection asks you to protect one appointment a week and to be able to say precisely when it happened. A daily one asks you to build a habit sturdy enough to survive travel, illness and ordinary Tuesdays. Neither is harder than the other. They just break differently, and the tracking that suits one is not the tracking that suits the other.
Frequently asked questions
Why is Ozempic weekly but Victoza daily?
Because the molecules clear at very different speeds. Ozempic is semaglutide, with a half-life of about one week, so a level built up by one injection is still substantial seven days later. Victoza is liraglutide, with a half-life of about 13 hours, so a meaningful share of it is gone by the next morning. The schedule on each box follows from that number rather than from any preference.
What was changed about GLP-1 molecules to make weekly dosing possible?
Two things. The molecule was modified to resist DPP-4, the enzyme that takes the natural hormone apart within about two minutes. And a fatty acid chain was attached that binds to albumin, an abundant protein in the blood, which both shields the molecule from that enzyme and slows how quickly the kidneys filter it out. Semaglutide binds albumin strongly through a fatty diacid chain, which is why it lasts about a week.
Why is Rybelsus taken daily if semaglutide lasts about a week?
Because the reason is absorption rather than half-life. Rybelsus is oral semaglutide, the same long-lasting molecule that is weekly as an injection, but only a small fraction of a swallowed dose is absorbed, and that absorption depends on strict conditions: an empty stomach, plain water only up to about 4 oz or 120 ml, and a wait of at least 30 minutes before food, other drinks or other oral medications. Daily dosing is what makes it dependable.
Is a weekly GLP-1 better than a daily one?
Cadence is a property of the molecule, not a ranking. A weekly injection asks you to protect one appointment a week and to know exactly when it happened, since missed-dose windows are counted in days and hours. A daily one asks for a habit sturdy enough to survive travel and illness. Which medication suits you depends on your history, your tolerance and your prescriber's judgment, not on the schedule alone.
Does a shorter half-life mean the medication is weaker?
No. Half-life describes how quickly a medication clears, not how strongly it acts while it is present. A short half-life means a shorter dosing interval, which is why exenatide is taken twice a day and liraglutide once a day. It also has a practical upside: a fast-clearing medication gives your prescriber quicker feedback if a dose does not sit well. Effectiveness is a separate question and a clinical one.